NCT07359079

The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

A Prospective, Multicenter, Randomized, Parallel-Controlled, Subject-Blinded, Evaluator-Blinded, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of PEGDE-crosslinked Hyaluronic Acid Hydrogels for the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 356 (actual)
• Sponsor: Chongqing Jinsaixing Medical Technology Co., Ltd · Industry
• Sex: All
• Age: 26 Years
• Healthy volunteers: Not accepted

Summary

The objective of this clinical trial is to evaluate the efficacy and safety of PEGDE-crosslinked hyaluronic acid hydrogels for the correction of midface volume deficiency and/or midface contour deficiency, on the premise of ensuring the safety of the subjects and maintaining the scientific integrity of the clinical trial.

Conditions

• the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

Interventions

Type	Name	Description
PROCEDURE	Stimulate	the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
BIOLOGICAL	Restylane Volyme	the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

Timeline

• Start date: 2025-03-19
• Primary completion: 2026-11-01
• Completion: 2027-02-27
• First posted: 2026-01-22
• Last updated: 2026-01-22

Locations

1 site across 1 country: China